The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 23% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $4.
Baozun Inc.
BZUN · Nasdaq · USD · Market cap $143M
FAIL · Does not pass the screenPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price3.29 USD at the 18 Nov 2026 close
- Fair valueUnder review: there is no analyst estimate to cross-check it; our model's value is 2.11x the price, above our 2.00x limit.
- Our regime readMarkdown, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-18).
- Trend Markdown
- Insiders insiders bought, latest filing 2026-10-21
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Baozun Inc. holds its Markdown at $3.29. Consolidating, no directional conviction, held for 1 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $3.29 |
| Valuation | 0.00 trailing · 4.21 forward price to earnings |
| Values screen | FAIL |
Five Screens: BZUN's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 1,354.64% | Below 33% | Fail |
| Interest-bearing cash | 1,856.25% | Below 33% | Fail |
| Receivables | 0.00% | Below 49% | Pass |
| Revenue purity | 0.59% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Baozun's business is in a permissible area, but its interest-bearing debt is about 1355% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BZUN's ethical verdict changes
Today BZUN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. There is no analyst estimate to cross-check it; our model's value is 2.11x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Model construction and limits: fair-value methodology.
Price History & ProjectionsWhere our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 4.2xcheap for a company growing this fast |
| Trailing P/E | 0.0x |
| EPS, trailing | -0.62 |
| EPS, forward | 0.70 |
| Revenue growth | +5.9%slow but positive growth |
| Profit margin | -2.4%currently unprofitable |
| Return on equity | -3.5%not currently earning a positive return on equity |
| Debt to equity | 0.35minimal debt: a conservative balance sheet |
| Moat | WEAK |
| Market cap | $143M |
BZUN-specific watchpoints · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 10.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $4.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $4.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 13.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $4.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $4.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $4.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $4.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $4.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-21 | Qiu Wenbin | CEO | P - Purchase | 11,400 | $39,900 |
| 2026-09-18 | Qiu Wenbin | CEO | P - Purchase | 13,900 | $39,825 |
| 2026-04-17 | QIU WENBIN VINCENT | Chief Executive Officer | 16,000 | $50,240 | |
| 2026-04-14 | QIU WENBIN VINCENT | Chief Executive Officer | 23,600 | $60,253 | |
| 2026-04-13 | WU JUNHUA | Officer and Director | 16,456 | $40,492 | |
| 2026-04-10 | QIU WENBIN VINCENT | Chief Executive Officer | 24,050 | $60,189 | |
| 2026-04-08 | QIU WENBIN VINCENT | Chief Executive Officer | 23,600 | $60,048 | |
| 2026-04-08 | WU JUNHUA | Officer and Director | 30,886 | $78,450 | |
| 2026-04-02 | WU JUNHUA | Officer and Director | 30,000 | $74,019 | |
| 2026-03-31 | WU JUNHUA | Officer and Director | 14,000 | $33,597 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $3.84 | -14.2% | · | $858 | -14.2% |
| 2 months | $2.85 | +15.4% | · | $1,154 | +15.4% |
| 3 months | $2.80 | +17.5% | · | $1,175 | +17.5% |
| 6 months | $2.50 | +31.6% | · | $1,316 | +31.6% |
| 1 year | $2.96 | +11.2% | · | $1,112 | +11.2% |
| 2 years | $2.54 | +29.5% | · | $1,295 | +29.5% |
| 3 years | $3.04 | +8.2% | · | $1,082 | +8.2% |
| 5 years | $16.84 | -80.5% | · | $195 | -80.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BZUN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.